Back
Speaker illustration

Doctor Peizhi Wang

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

Peizhi Wang, MD, completed his PhD training at Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), China, and as a joint PhD student under the supervision of Professor Thomas Lüscher and Dr. Florian Wenzl at the Center for Molecular Cardiology, University of Zurich, Switzerland, where he continues as a visiting scholar. Currently, he is a postdoctoral researcher in the Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, CAMS & PUMC, Beijing, under the supervision of Professor Shuyang Zhang. His research focuses on risk stratification, artificial intelligence, and multiomics novel biomarkers.

Presentations Articles

External validation of the CA-AKI score in patients with acute coronary syndrome: A real-world cohort analysis from Asia

Event: ESC Congress 2024

Topic: Renal Failure and Cardiovascular Disease

Session: Impact of chronic kidney disease on cardiovascular outcomes

Access
Like
Thumbnail

Proenkephalin improves risk prediction in acute coronary syndromes: derivation and external validation of the KID-ACS risk score

Event: ESC Congress 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Cardiovascular diseases: predictors of onset and prognosis

Access
Like
Thumbnail

L-shaped association of lipoprotein(a) on long-term bleeding risk in patients with coronary heart disease: insight from a multicenter cohort in Asia

Event: ESC Congress 2023

Topic: Lipids

Session: Risk factors and prevention: lipids (5)

Access
Like
Thumbnail

The impact of the high-density lipoprotein cholesterol levels on long-term poor prognosis in patients with acute coronary syndrome: observations from a multicenter Asian cohort study

Event: ESC Acute CardioVascular Care 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Biomarkers and risk stratification in Acute Coronary Syndromes

Access
Like
Thumbnail

Effect of the stress hyperglycemia ratio on long-term outcome in older patients with coronary heart disease: a multicenter cohort study

Event: ESC Acute CardioVascular Care 2023

Topic: Secondary Prevention

Session: Novel topics in acute cardiac care

Access
Like
Thumbnail

High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort

Event: ESC Preventive Cardiology 2022

Topic: Percutaneous Coronary Intervention (PCI)

Session: Rapid fire abstracts session 1 - Secondary Prevention and Rehabilitation

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources